LCE3D Inhibitors
LCE3D inhibitors represent a distinctive category within the realm of biochemical research, focusing on the inhibition of the Late Cornified Envelope 3D (LCE3D) protein. This protein is part of the Late Cornified Envelope (LCE) gene family, which plays a significant role in skin biology, particularly in the development and maintenance of the epidermal barrier. The LCE3D protein is involved in the formation of the cornified envelope, a critical component in the outermost layer of the skin that provides a protective barrier against environmental insults and helps maintain hydration. By targeting the LCE3D protein, these inhibitors affect the process of cornification, where cells in the epidermis develop into hardened, flat cells that form the protective outer layer. The action of LCE3D inhibitors is marked by their ability to selectively interact with the LCE3D protein, thereby influencing its activity. This specificity is crucial for the desired modulation of the LCE3D protein's function, with minimal impact on other proteins within the LCE gene family or other related pathways in skin physiology. LCE3D inhibitors can also interact with pathways involved with the LCE3D protein in order to indirectly inhibit it.
The chemical structures of LCE3D inhibitors are varied, reflecting the complexity of their target interactions. This diversity in structure is instrumental in achieving different levels of binding affinity and specificity towards the LCE3D protein. Additionally, research into LCE3D inhibitors contributes to a broader understanding of skin biology, particularly regarding the epidermal differentiation complex (EDC), where the LCE gene family resides. This research not only enhances our knowledge of the molecular mechanisms governing the formation of the skin barrier but also illuminates the complex network of proteins involved in skin homeostasis, shedding light on the intricate processes that underpin epidermal development and maintenance.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A potent protein kinase C inhibitor that may lead to diminished LCE3D expression by inhibiting the PKC-dependent signaling pathways crucial for keratinocyte differentiation, where LCE3D is involved. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
A metabolite of Vitamin A that can regulate keratinocyte proliferation and differentiation; altered retinoid signaling could indirectly decrease LCE3D expression, which is part of the epidermal differentiation complex. | ||||||
Calcipotriol | 112965-21-6 | sc-203537 sc-203537A | 10 mg 50 mg | $203.00 $832.00 | 4 | |
A Vitamin D analog that binds to the vitamin D receptor (VDR) in keratinocytes, regulating cell differentiation and potentially diminishing LCE3D expression as it is part of the late differentiation program of epidermal keratinocytes. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Binds to the cytosolic protein cyclophilin of lymphocytes, inhibiting calcineurin and thus T-cell activation. This could diminish the inflammatory response, indirectly reducing LCE3D expression linked to inflammatory signals in the skin. | ||||||
Hydrocortisone | 50-23-7 | sc-300810 | 5 g | $102.00 | 6 | |
A glucocorticoid that can suppress gene expression related to immune responses and inflammation; by diminishing inflammatory signaling in the skin, it may indirectly decrease LCE3D expression, which can be upregulated during inflammatory responses. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
May diminish the expression of LCE3D by reducing the proliferation of keratinocytes and the inflammatory signaling that can upregulate LCE3D during immune reactions. | ||||||
Imiquimod | 99011-02-6 | sc-200385 sc-200385A | 100 mg 500 mg | $67.00 $284.00 | 6 | |
Acts as an agonist of Toll-like receptor 7, potentially diminishing LCE3D expression by altering the local immune environment and keratinocyte differentiation states where LCE3D is typically upregulated. | ||||||
Cerulenin (synthetic) | 17397-89-6 | sc-200827 sc-200827A sc-200827B | 5 mg 10 mg 50 mg | $161.00 $312.00 $1210.00 | 9 | |
A fatty acid synthase inhibitor that may lead to altered lipid synthesis in keratinocytes; this could indirectly affect the differentiation process and diminish LCE3D expression, as LCE3D is associated with late differentiation stages of epidermal keratinocytes. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
A MEK inhibitor that blocks the MAPK/ERK pathway, potentially diminishing LCE3D expression by affecting keratinocyte differentiation processes in which LCE3D is involved. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
An N-glycosylation inhibitor that could lead to ER stress and the unfolded protein response in keratinocytes, potentially diminishing LCE3D expression by affecting cellular stress pathways and keratinocyte differentiation programs. | ||||||